statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	19.483
EU - Europa	11.373
AS - Asia	7.262
SA - Sud America	1.276
AF - Africa	137
OC - Oceania	8
Continente sconosciuto - Info sul continente non disponibili	5
Totale	39.544

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	19.269
IT - Italia	6.438
SG - Singapore	2.888
UA - Ucraina	1.671
CN - Cina	1.390
VN - Vietnam	1.303
HK - Hong Kong	1.099
BR - Brasile	1.075
IE - Irlanda	744
DE - Germania	634
GB - Regno Unito	447
FR - Francia	393
SE - Svezia	384
RU - Federazione Russa	342
FI - Finlandia	116
TR - Turchia	96
BD - Bangladesh	95
IN - India	92
AR - Argentina	86
MX - Messico	86
CA - Canada	79
JP - Giappone	77
ID - Indonesia	43
ZA - Sudafrica	35
EC - Ecuador	31
NG - Nigeria	31
PK - Pakistan	31
AT - Austria	30
PL - Polonia	30
IQ - Iraq	29
NL - Olanda	28
CO - Colombia	26
ES - Italia	26
MA - Marocco	17
UZ - Uzbekistan	17
KE - Kenya	16
SA - Arabia Saudita	16
PY - Paraguay	15
TT - Trinidad e Tobago	14
VE - Venezuela	14
MY - Malesia	12
PH - Filippine	12
CZ - Repubblica Ceca	11
LT - Lituania	11
CH - Svizzera	10
CL - Cile	9
JM - Giamaica	9
PE - Perù	9
TN - Tunisia	9
BE - Belgio	8
EG - Egitto	8
DO - Repubblica Dominicana	7
DZ - Algeria	7
HU - Ungheria	7
RO - Romania	7
AE - Emirati Arabi Uniti	6
AU - Australia	6
HN - Honduras	6
MD - Moldavia	6
UY - Uruguay	6
AL - Albania	5
IL - Israele	5
NP - Nepal	5
BO - Bolivia	4
BY - Bielorussia	4
ET - Etiopia	4
GR - Grecia	4
KR - Corea	4
KZ - Kazakistan	4
OM - Oman	4
PR - Porto Rico	4
AM - Armenia	3
BG - Bulgaria	3
DK - Danimarca	3
EU - Europa	3
GT - Guatemala	3
JO - Giordania	3
KH - Cambogia	3
LB - Libano	3
MM - Myanmar	3
TW - Taiwan	3
AZ - Azerbaigian	2
BB - Barbados	2
CG - Congo	2
GE - Georgia	2
HR - Croazia	2
RS - Serbia	2
SN - Senegal	2
SX - ???statistics.table.value.countryCode.SX???	2
TH - Thailandia	2
AO - Angola	1
BH - Bahrain	1
BJ - Benin	1
BN - Brunei Darussalam	1
BW - Botswana	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
EE - Estonia	1
GA - Gabon	1
IR - Iran	1
Totale	39.524

Salva come PNG Salva come JPEG

Città	#
Milan	4.690
Fairfield	2.726
Ashburn	2.228
San Jose	1.624
Singapore	1.447
Woodbridge	1.282
Seattle	1.092
Hong Kong	1.091
Wilmington	1.035
Houston	1.027
Cambridge	930
Jacksonville	881
Dublin	730
Princeton	646
Rome	466
The Dalles	450
Dallas	438
Boardman	429
Ann Arbor	398
Chandler	390
Lauterbourg	344
Beijing	336
Dong Ket	327
Ho Chi Minh City	252
Nyköping	231
Council Bluffs	229
San Diego	219
Washington	204
Chicago	191
Los Angeles	162
New York	159
London	154
Hanoi	152
Ogden	135
Helsinki	102
Santa Clara	92
São Paulo	80
Tokyo	73
Kocaeli	53
Mexico City	50
Como	47
Guangzhou	46
Shanghai	44
Orem	42
Salt Lake City	42
Buffalo	40
Rio de Janeiro	37
Munich	36
Brooklyn	33
Atlanta	30
Chennai	30
Haiphong	29
Hangzhou	29
Belo Horizonte	28
Frankfurt am Main	28
Abuja	27
Nuremberg	26
Tampa	26
Des Moines	25
San Francisco	25
Da Nang	24
Warsaw	24
Brasília	23
Johannesburg	23
Norwalk	23
Stockholm	23
Prescot	22
Elk Grove Village	21
Phoenix	21
Porto Alegre	21
Montreal	19
Kilburn	18
Toronto	18
Vienna	18
Zhengzhou	18
Biên Hòa	17
Denver	17
Treviglio	17
Amsterdam	16
Hefei	16
Hải Dương	16
Kunming	16
Las Vegas	16
Redmond	16
Boston	15
Miami	15
Tashkent	15
Shenzhen	14
Thái Nguyên	14
Chiswick	13
Curitiba	13
Lancaster	13
Manchester	13
Nanjing	13
Baghdad	12
Fortaleza	12
Istanbul	12
Nairobi	12
Redwood City	12
Thái Bình	12
Totale	28.888

Salva come PNG Salva come JPEG

Nome	#
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	279
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	221
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	204
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	201
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	199
Fibrillazione atriale e morte cardiaca improvvisa: Un mistero da risolvere?	199
Association between periodontal disease and left ventricle mass in essential hypertension	195
The revolution of the anti-diabetic drugs in cardiology	186
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	173
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	165
Microcirculation and left-ventricular hypertrophy	162
Good news for beta-blockers in perioperative medicine	161
Adverse prognostic significance of new diabetes in treated hypertensive subjects	159
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	156
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	156
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	153
Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study	151
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	149
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	149
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	149
Ablation of atrial tachycardia in the setting of prior mitral valve surgery	149
Sudden Cardiac Death in Hypertensive Patients	145
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	144
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	143
How important is to reduce sodium and increase potassium in patients with hypertension?	142
The optimal blood pressure target for patients with coronary artery disease	141
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	139
Electrocardiographic features of patients with COVID-19 pneumonia	139
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	139
Angiotensin-converting enzyme inhibitors	138
Atrial fibrillation in hypertension - Predictors and outcome	138
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	137
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	137
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	137
Modernization and hypertension: is the link changing?	137
Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients	137
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects	136
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	136
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	135
Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial	134
Short- and long-term incidence of stroke in white-coat hypertension	133
Telmisartan for the reduction of cardiovascular morbidity and mortality	133
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	132
The emerging role of high-density lipoprotein cholesterol in hypertension trials	132
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	132
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	132
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	132
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	132
Role of ambulatory blood pressure monitoring in prehypertension	130
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	130
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	130
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	130
COVID-19: ACE2centric infective disease?	130
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection	130
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	129
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	129
Aliskiren versus ramipril in hypertension	129
Ambulatory blood pressure for cardiovascular risk stratification	129
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	129
White-coat hypertension in adults	128
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	128
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	128
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	128
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	128
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	128
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	128
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	127
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	127
Adverse prognostic significance of new diabetes in treated hypertensive subjects	127
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	126
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	126
Does Malaria Cause Hypertension?	126
Natural history of hypertension subtypes	126
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	126
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	126
"From Apennines to Andes:" Does Body Mass Index Affect the Relationship Between Age and Blood Pressure?	126
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value	126
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	125
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	125
The clinical significance of white-coat and masked hypertension	125
New-onset diabetes in treated hypertensive patients	124
ABPM in the prognostic evaluation of hypertensive patients	123
Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons	123
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	123
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	123
ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus	123
Catheter ablation of atrial tachycardias after mitral valve surgery: A systematic review and meta-analysis	123
Estimate of white-coat effect and arterial stiffness	122
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome	122
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	122
"The Lower the BP the Better" Paradigm in the Elderly Vanished by VALISH?	121
European and US guidelines for arterial hypertension: similarities and differences	121
EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION	121
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty?	121
Raas inhibitors and risk of COVID-19	121
Hypertension and Atrial Fibrillation Doubts and Certainties From Basic and Clinical Studies	120
Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial	120
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients	120
Clinical usefulness of ambulatory blood pressure monitoring	120
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study	120
Totale	13.926

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	197.437
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	197.437

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	883	0	0	0	0	0	0	0	0	0	0	0	883
2021/2022	2.824	269	503	59	87	82	120	182	219	193	442	304	364
2022/2023	1.998	338	75	81	143	90	508	15	228	242	168	56	54
2023/2024	7.937	1.109	1.235	1.190	1.475	1.744	767	45	61	198	39	11	63
2024/2025	4.485	15	41	924	82	79	264	181	167	655	270	402	1.405
2025/2026	10.493	678	587	683	1.732	512	435	2.123	809	1.452	692	526	264
Totale													40.038